July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
First Application of 3D Near-Vision Test for near vision examination in pediatric patients without polarized glasses: a new clinical evaluation of stereopsis.
Author Affiliations & Notes
  • Luigi Marino
    Dry Eye Center, Istituto Europeo Occhio Secco - Lugano- Milano, Milano, Italy
  • Davide Borroni
    Department of Ophthalmology, Riga Stradins University, Riga, Latvia
  • Melanie Ferronato
    School of Medicine, Riga Stradins University, Riga, Latvia
  • Mohit Parekh
    International Center for Ocular Physiopathology (ICOP), Venice Eye Bank - FBOV, Mestre, Italy
  • Sabino Pisani
    Dry Eye Center, Istituto Europeo Occhio Secco - Lugano- Milano, Milano, Italy
  • Footnotes
    Commercial Relationships   Luigi Marino, None; Davide Borroni, None; Melanie Ferronato, None; Mohit Parekh, None; Sabino Pisani, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5197. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Luigi Marino, Davide Borroni, Melanie Ferronato, Mohit Parekh, Sabino Pisani; First Application of 3D Near-Vision Test for near vision examination in pediatric patients without polarized glasses: a new clinical evaluation of stereopsis. . Invest. Ophthalmol. Vis. Sci. 2018;59(9):5197.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Vision screening and eye examination are vital for the detection of conditions that suppress the normal visual image and may lead to inadequate school performance and blindness in children. Sometimes, collaboration with patient younger that 6 y.o. is challenging. In this study we evaluated the new 3D-Vision System by REALVISION that doesn’t need use of eye glasses. <div class="grammarly-disable-indicator"> </div>

Methods : This was a cross-sectional study evaluating the REALVISION KIT NEAR by REALVISION Srl. in acquired strabismus and normal subjects after approval from the Institutional review board of Riga Stradins University. The inclusion criteria were subjects aged six years and above, with an onset of deviation after the first year of life, best corrected visual acuity (BCVA) of 0.3 or better in each eye at the time of examination. We included children with anisometropia, divided into groups with amblyopic anisometropia (AA n = 25) and non-amblyopic anisometropia (NA n = 58)). Control group (n = 31). Main outcome measures were the level of stereopsis, sensory fusion and collaboration of the patient. <div class="grammarly-disable-indicator"> </div>

Results : The degree of anisometropia in the NA, AA, and control groups was 2.41 diopters (D), 3.59 D, and 0.20 D, respectively (P = 0.014). Stereopsis (arcsec) was significantly worse in the AA group than the NA and control groups (631.71, 72.25, 51.52, respectively, P < 0.001), while no significant difference was found between the NA and control groups. The rate of fusion was significantly lower in the AA than the NA group (14.3% vs. 65.3%, P < 0.001), and was significantly lower in the NA than the control group (65.3% vs. 80.6%, P = 0.001). In 8 patients (5 NA and 3 AA) the standard tests were not able to be performed and only 3D Airplane test got the attention of the children. <div class="grammarly-disable-indicator"> </div>

Conclusions : The levels of stereopsis and sensory fusion with anisometropic glasses were significantly worse in the AA than in the NA group. The REALVISION KIT NEAR gives the possibility to improve the collaboration with patients, especially the 3D Airplane tests who extend the range of patient that can have a possibile benefit from an eye consultation. <div class="grammarly-disable-indicator"> </div>

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×